ArticleClinical and experimental immunology2019

Protein-engineered molecules carrying GAD65 epitopes and targeting CD35 selectively down-modulate disease-associated human B lymphocytes.

I K Manoylov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.